Skip to content

Mediclinic Int plc (JSE: MEI) | Share Price

Nigel Firth
Nigel Frith trader
Updated 2 Sep 2022

Mediclinic Int plc is a diversified international private healthcare services company listed on the Johannesburg Stock Exchange (JSE) that was founded in South Africa but has divisions in Switzerland, Southern Africa (South Africa and Namibia), and the United Arab Emirates.

Latest Mediclinic Int plc Share Price

The graph above shows the latest Mediclinic Int plc share price on the Johannesburg Stock Exchange. Investors have seen Mediclinic Int plc shares perform well historically, and it remains a steady investment. Mediclinic Int plc stock is live on the JSE under the stock symbol of MEI and is available to trade via various brokers in South Africa.

What is Mediclinic Int plc

Mediclinic is focused on putting patients at the heart of its operations and consistently delivering high-quality healthcare services. The Group upholds the highest standards of clinical governance and ethical behaviour across its divisions; invests substantial time and resources in recruiting and retaining skilled employees; makes significant investment into its facilities and equipment and respects the communities and environment in the areas in which it operates.

The history of Mediclinic Int plc can be traced back to 3 October 1983. Today, Mediclinic Int plc has a diversified portfolio of products and services in more sectors of the Health Care value chain and renders the following services: specialist-orientated, multi-disciplinary services across the spectrum of care and is trusted by patients, medical practitioners, funders and regulators of healthcare in all of its markets.

It runs approximately 74 hospitals, five subacute hospitals, two mental health facilities, 19 day case clinics and 20 outpatient clinics.

Mediclinic Int plc’s equity stocks are for sale online on the Johannesburg Stock Exchange (JSE) under the stock symbol MEI. The Company’s primary listing is on the London Stock Exchange (LSE) in the United Kingdom, with secondary listings on the JSE in South Africa and the Namibian Stock Exchange in Namibia.

Mediclinic also holds a 29.9% interest in the Spire Healthcare Group, a leading private healthcare group based in the United Kingdom and listed on the LSE.

Mediclinic Int plc has its headquarters at 6th Floor, 65 Gresham Street, London, United Kingdom, EC2V 7NQ.

Mediclinic Int plc has more than 33 140 employees and currently serves clients in areas like South Africa, Namibia, Switzerland and the United Arab Emirates.

The current CEO of Mediclinic Int plc is Ronnie van der Merwe.

Mediclinic Int plc forms part of the Health Care sector, specifically, the Equipment & Services industry of the Johannesburg Stock Exchange (JSE).

Buy Shares
Mediclinic Int plc

Mediclinic Int plc Stock Performance

The most recent or current price for Mediclinic Int plc stocks on the Johannesburg Stock Exchange (JSE) was 68.49 ZAR at the time of writing.

An analysis of financial data of Mediclinic Int plc showed that the company has a total market capitalisation of 50.5 Billion ZAR, with a Price/Earning ratio of 20.89 and earnings per share of 3.2784 ZAR. A total of 737 Million shares were outstanding.

With an increase of earnings per share and reliable profits over a period, investors who want to buy or sell Mediclinic Int plc stocks can be hopeful for lucrative dividends and earnings in times to come.

According to an analysis on the live chart of Mediclinic Int plc, analysts forecast a possible further improved performance for the Health Care sector with market share growing as trading volumes increase.


Highlights of Mediclinic Int plc in 2021

Mediclinic Int plc started the current financial year (2021) with a share price of 68.06 ZAR on the Johannesburg Stock Exchange (JSE), and it has gained 0.63 % in value on its price valuation, ranking 170th on the JSE with its year-to-date performance.

Mediclinic Int plc is currently the 68th most-traded stock on the JSE and it has experienced a total trading volume of more than 71.2 million shares, which were finalised in 97,667 deals and were valued at a total of 4.77 billion ZAR over a recent three month period from October 2021 to January 2022, with an average of 1.13 million shares in each trading session.

During the same period a volume high of 4.31 million was achieved on November 11 and a low of 41,613 on December 24.

How to buy Mediclinic Int plc stocks – Step by Step

The stock market is one of the most attractive financial markets that sees millions of retail investors and traders' participating daily. To buy, sell or trade Mediclinic Int plc stocks on the Johannesburg Stock Exchange (JSE), traders and investors can follow a few simple steps:

  1. Find the share that you want to buy, in this case, “MEI”.
  2. Select a forex broker that offers access to the Johannesburg Stock Exchange (JSE).
  3. Review the broker's trading conditions, fees, deposit and withdrawal methods, trading platform, customer support, regulation, and other components to ensure that they are aligned with your trading plan.
  4. Open a live trading account with the broker by completing the online application form and providing the necessary documentation to verify the trading account.
  5. You are now ready to make your first share purchase through the broker.
  6. You can further start to build and diversify your portfolio by buying more shares.


The Johannesburg Stock Exchange (JSE) was founded in 1887 during the first South African gold rush. Today it is the principal stock exchange of South Africa and the largest exchange on the continent.

The Johannesburg Stock Exchange is located in Sandton, Johannesburg and is described as the engine room of the South African economy, with the main purpose of facilitating the raising of primary capital for listed companies while improving job opportunities and wealth creation by providing an orderly market for dealing in securities for investors.

Nigel Firth
Nigel has been in the regulated financial services industry for nearly a decade, has previously owned a financial brokerage and has written many times for sites relating to personal finance and trading.